H1N1 Nasal Spray Vaccine (cont.)
IN THIS ARTICLE
Nasal-spray flu vaccine, ill patients, passing the vaccine virus to others, and immunocompromised patients
Can the nasal-spray flu vaccine be given to patients when they are ill?
The nasal-spray flu vaccine can be given to people with minor illnesses (e.g., diarrhea or mild upper respiratory tract infection with or without fever). However, if nasal congestion is present that might limit delivery of the vaccine to the nasal lining, then delaying of vaccination until the nasal congestion is reduced should be considered.
Can people receiving the nasal-spray flu vaccine LAIV pass the vaccine viruses to others?
In clinical studies, transmission of vaccine viruses to close contacts occurred only rarely. The current estimated risk of getting infected with vaccine virus after close contact with a person vaccinated with the nasal-spray flu vaccine is low (0.6%-2.4%). Because the viruses are weakened, infection is unlikely to result in influenza illness symptoms since the vaccine viruses have not been shown change into typical or naturally occurring influenza viruses.
Can contacts of people with weakened immune systems get the nasal-spray flu vaccine?
People who are in contact with others with severely weakened immune systems when they are being cared for in a protective environment (for example, people with hematopoietic stem cell transplants), should not get the nasal spray vaccine, including the 2009 H1N1 nasal spray vaccine if they will come into contact with the severely immunocompromised person within 7 days of vaccination. People who have contact with others with lesser degrees of immunosuppression (for example, people with diabetes, people with asthma taking corticosteroids, or people infected with HIV) can get the nasal spray vaccine.
Must Read Articles Related to H1N1 Nasal Spray Vaccine
Find out what women really need.